Investing Center Preview – Manage your investments and watch your net worth grow.
APLM:NASDAQ – Small Cap Stock (Biotechnology)
Apollomics Inc – APLM Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
6.00 | -0.71 (-10.58%) | 4.95 - 63.00 | 21.9 thousand (Below Avg) |
Market data as of 3:57PM 04/04/25. Quotes are delayed by at least 15 min.
Overview - APLM
Open | 6.58 |
---|---|
Previous Close | 6.71 |
Day's Range | 4.95 - 6.58 |
Market Cap | 6.6M |
Avg Volume (10 Day) | 75.9K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -23.2 |
Dividend Yield | No Dividend |
One-Click Scorecard - APLM


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Fail |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Fail |
Borrows within reasonable limits? | Neutral |
Stock is undervalued? | Fail |
Have investors caught on? | Neutral |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - APLM
No news headlines available for APLM
Industry Position - APLM
APLM | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.23 | |
LT Debt/Equity | 0.05 | |
Earnings Yield | -- | |
Price/Sales | -- |
Competitors - APLM
Company | Last | Change |
---|---|---|
Enzon Pharmaceuticals Inc | 0.10 | 0.00% |
Lyra Therapeutics Inc | 0.12 | +8.55% |
Cytophage Technologies Ltd | 0.14 | 0.00% |
Acurx Pharmaceuticals Inc | 0.32 | -3.03% |
1.02 | -13.56% |
Data is delayed by at least 15 min.